5 Best Low Volatility Blue Chip Stocks to Buy Now

Page 5 of 5

1. Johnson & Johnson (NYSE:JNJ)

Beta Value (5Y Monthly): 0.33

On April 7, Citi lifted its price recommendation on Johnson & Johnson (NYSE:JNJ) to $285 from $274. The firm kept a Buy rating as it updated its outlook for the medical technology group ahead of Q1. The analyst said the “walls of worry are high” going into earnings, with the sector facing meaningful multiple compression. Citi also made some changes to its top picks, removing iRhythm and Medtronic. Its preferred names now include Edwards Lifesciences and Intuitive Surgical.

That same day, Goldman Sachs reiterated a Buy rating on Johnson & Johnson with a $265 price target ahead of Q1 results. The firm pointed to a “banner year” in 2025, driven by a turnaround in the Innovative Medicines business after the Stelara loss of exclusivity, along with stabilization in MedTech. The analyst added that shares have continued to outperform in 2026 so far, as the story shifts toward commercial momentum. New product cycles are supporting a re-rating, with expectations of a sustained period of accelerating growth.

Johnson & Johnson (NYSE:JNJ) operates across the healthcare sector, focusing on research, development, manufacturing, and sales. Its business is organized into two segments: Innovative Medicine and MedTech.

While we acknowledge the potential of JNJ as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than JNJ and that has 100x upside potential, check out our report about the cheapest AI stock.

READ NEXT: 15 Cheapest Stocks with Highest Dividends and 15 Best Consistent Dividend Stocks to Buy Right Now

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

Page 5 of 5